肺结核分子诊断技术的研究进展
Research Progress on Molecular Diagnostic Techniques for Pulmonary Tuberculosis
DOI: 10.12677/acm.2025.1592507, PDF,   
作者: 薛朵朵：延安大学附属医院呼吸内科，陕西 延安；毛雅萌, 李 洋：延安大学附属医院消化内科，陕西 延安；白智远*：延安大学附属医院心脑血管医院老年呼吸内科，陕西 延安
关键词: 肺结核；分子诊断；Pulmonary Tuberculosis； Molecular Diagnosis
摘要: 肺结核(pulmonary tuberculosis, PTB)作为一种通过呼吸道传播且严重威胁健康的疾病，其早期发现、诊断和治疗对疾病控制极为关键。然而，传统的诊断方法常因影响因素多、灵敏度不高、耗时较长而存在局限。如今，新兴的分子诊断技术凭借快速检测、高灵敏度及高特异性等突出优势，正在临床上得到越来越广泛的运用。本文的主要目的，是对当下结核分子诊断技术所取得的进展展开全面综述，进而为我国结核病的诊断与治疗工作提供有价值的参考。
Abstract: Pulmonary tuberculosis, as a disease transmitted through the respiratory tract that poses a serious threat to health, requires early detection, diagnosis and treatment, which are crucial for disease control. However, traditional diagnostic methods are often limited by multiple influencing factors, low sensitivity and lengthy processing times. Nowadays, emerging molecular diagnostic technologies, with their outstanding advantages such as rapid detection, high sensitivity and high specificity are being increasingly widely applied in clinical practice. The primary objective of this paper is to provide a comprehensive review of the current progress in molecular diagnostic technologies for tuberculosis, thereby offering valuable references for the diagnosis and treatment of tuberculosis in China.
文章引用：薛朵朵, 毛雅萌, 李洋, 白智远. 肺结核分子诊断技术的研究进展[J]. 临床医学进展, 2025, 15(9): 419-424. https://doi.org/10.12677/acm.2025.1592507

参考文献

[1] World Health Organization (2019) Global Tuberculosis Report 2019.
https://www.who.int/tb/publications/global_report/en/
[2] World Health Organization (2024) Global Tuberculosis Report 2024. World Health Organization.
[3] Sakula, A. (1982) Robert Koch: Centenary of the Discovery of the Tubercle Bacillus, 1882. Thorax, 37, 246-251. [Google Scholar] [CrossRef] [PubMed]
[4] Lange, C., Abubakar, I., Alffenaar, J.C., Bothamley, G., Caminero, J.A., Carvalho, A.C.C., et al. (2014) Management of Patients with Multidrug-Resistant/Extensively Drug-Resistant Tuberculosis in Europe: A TBNET Consensus Statement. European Respiratory Journal, 44, 23-63. [Google Scholar] [CrossRef] [PubMed]
[5] Acharya, B., Acharya, A., Gautam, S., Ghimire, S.P., Mishra, G., Parajuli, N., et al. (2020) Advances in Diagnosis of Tuberculosis: An Update into Molecular Diagnosis of Mycobacterium tuberculosis. Molecular Biology Reports, 47, 4065-4075. [Google Scholar] [CrossRef] [PubMed]
[6] Lewinsohn, D.M., Leonard, M.K., LoBue, P.A., Cohn, D.L., Daley, C.L., Desmond, E., et al. (2017) Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clinical Infectious Diseases, 64, 111-115. [Google Scholar] [CrossRef] [PubMed]
[7] Steingart, K.R., Ramsay, A. and Pai, M. (2007) Optimizing Sputum Smear Microscopy for the Diagnosis of Pulmonary Tuberculosis. Expert Review of Anti-infective Therapy, 5, 327-331. [Google Scholar] [CrossRef] [PubMed]
[8] Cuevas, L.E., Browning, R., Bossuyt, P., Casenghi, M., Cotton, M.F., Cruz, A.T., et al. (2012) Evaluation of Tuberculosis Diagnostics in Children: 2. Methodological Issues for Conducting and Reporting Research Evaluations of Tuberculosis Diagnostics for Intrathoracic Tuberculosis in Children. Consensus from an Expert Panela. The Journal of Infectious Diseases, 205, S209-S215. [Google Scholar] [CrossRef] [PubMed]
[9] Oh, C., Roh, Y., Lim, D., Kong, H., Cho, H., Hwangbo, B., et al. (2020) Pulmonary Tuberculosis Is Associated with Elevated Risk of Lung Cancer in Korea: The Nationwide Cohort Study. Journal of Cancer, 11, 1899-1906. [Google Scholar] [CrossRef] [PubMed]
[10] Henschke, C.I., Yankelevitz, D.F., Miettinen, O.S. and International Early Lung Cancer Action Program Investigators (2006) Computed Tomographic Screening for Lung Cancer: The Relationship of Disease Stage to Tumor Size. Archives of Internal Medicine, 166, 321-325.
[11] 杨帆, 胡良安. 肺结核分子诊断方法研究进展[J]. 现代医药卫生, 2020, 36(22): 3593-3597.
[12] Diel, R., Goletti, D., Ferrara, G., Bothamley, G., Cirillo, D., Kampmann, B., et al. (2011) Interferon-γ Release Assays for the Diagnosis of Latent Mycobacterium tuberculosis Infection: A Systematic Review and Meta-Analysis. European Respiratory Journal, 37, 88-99.
[13] Lee, Y., Kim, S., Park, S.J., Park, K., Lee, S., Choi, S., et al. (2013) Indeterminate T-SPOT.TB Test Results in Patients with Suspected Extrapulmonary Tuberculosis in Routine Clinical Practice. Infection & Chemotherapy, 45, 44-50. [Google Scholar] [CrossRef] [PubMed]
[14] Blakemore, R., Story, E., Helb, D., Kop, J., Banada, P., Owens, M.R., et al. (2010) Evaluation of the Analytical Performance of the Xpert MTB/RIF Assay. Journal of Clinical Microbiology, 48, 2495-2501. [Google Scholar] [CrossRef] [PubMed]
[15] World Health Organization (2011) (978-92-4-150633-5). Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberciuosis and Rifampicin Resistance: Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children: Policy Update.
[16] Chang, K., Lu, W., Wang, J., Zhang, K., Jia, S., Li, F., et al. (2012) Rapid and Effective Diagnosis of Tuberculosis and Rifampicin Resistance with Xpert MTB/RIF Assay: A Meta-analysis. Journal of Infection, 64, 580-588. [Google Scholar] [CrossRef] [PubMed]
[17] Kay, A.W., Ness, T., Verkuijl, S.E., Viney, K., Brands, A., Masini, T., et al. (2022) Xpert MTB/RIF Ultra Assay for Tuberculosis Disease and Rifampicin Resistance in Children. Cochrane Database of Systematic Reviews, 9, CD013359. [Google Scholar] [CrossRef] [PubMed]
[18] Bisognin, F., Lombardi, G., Lombardo, D., Re, M.C. and Dal Monte, P. (2018) Improvement of Mycobacterium tuberculosis Detection by Xpert MTB/RIF Ultra: A Head-to-Head Comparison on Xpert-Negative Samples. PLOS ONE, 13, e0201934. [Google Scholar] [CrossRef] [PubMed]
[19] Zhang, M., Xue, M. and He, J. (2020) Diagnostic Accuracy of the New Xpert MTB/RIF Ultra for Tuberculosis Disease: A Preliminary Systematic Review and Meta-Analysis. International Journal of Infectious Diseases, 90, 35-45. [Google Scholar] [CrossRef] [PubMed]
[20] Wu, X., Tan, G., Gao, R., Yao, L., Bi, D., Guo, Y., et al. (2019) Assessment of the Xpert MTB/RIF Ultra Assay on Rapid Diagnosis of Extrapulmonary Tuberculosis. International Journal of Infectious Diseases, 81, 91-96. [Google Scholar] [CrossRef] [PubMed]
[21] Aricha, S.A., Kingwara, L., Mwirigi, N.W., Chaba, L., Kiptai, T., Wahogo, J., et al. (2019) Comparison of Genexpert and Line Probe Assay for Detection of Mycobacterium tuberculosis and Rifampicin-Mono Resistance at the National Tuberculosis Reference Laboratory, Kenya. BMC Infectious Diseases, 19, Article No. 852. [Google Scholar] [CrossRef] [PubMed]
[22] Pang, Y., Dong, H., Tan, Y., Deng, Y., Cai, X., Jing, H., et al. (2016) Rapid Diagnosis of MDR and XDR Tuberculosis with the Meltpro TB Assay in China. Scientific Reports, 6, Article No. 25330. [Google Scholar] [CrossRef] [PubMed]
[23] Arefzadeh, S., Azimi, T., Nasiri, M.J., Nikpor, Z., Dabiri, H., Doustdar, F., et al. (2020) High-Resolution Melt Curve Analysis for Rapid Detection of Rifampicin Resistance in Mycobacterium tuberculosis: A Single-Centre Study in Iran. New Microbes and New Infections, 35, Article ID: 100665. [Google Scholar] [CrossRef] [PubMed]
[24] Hu, S., Li, G., Li, H., Liu, X., Niu, J., Quan, S., et al. (2014) Rapid Detection of Isoniazid Resistance in Mycobacterium tuberculosis Isolates by Use of Real-Time-PCR-Based Melting Curve Analysis. Journal of Clinical Microbiology, 52, 1644-1652. [Google Scholar] [CrossRef] [PubMed]
[25] Notomi, T. (2000) Loop-Mediated Isothermal Amplification of DNA. Nucleic Acids Research, 28, e63. [Google Scholar] [CrossRef] [PubMed]
[26] World Health Organization (2016) The Use of Loop-Mediated Isothermal Amplification (TB-LAMP) for the Diagnosis of Pulmonary Tuberculosis: Policy Guidance. World Health organization.
[27] World Health Organization (2016) (978-92-4-151118-6). The Use of Loop-Mediated Isothermal Amplification (TB-Lamp) for the Diagnosis of Pulmonary Tuberculosis: Policy Guidance. World Health Organization.
[28] Shi, C., Han, P., Tang, P., Chen, M., Ye, Z., Wu, M., et al. (2020) Clinical Metagenomic Sequencing for Diagnosis of Pulmonary Tuberculosis. Journal of Infection, 81, 567-574. [Google Scholar] [CrossRef] [PubMed]
[29] Zhou, X., Wu, H., Ruan, Q., Jiang, N., Chen, X., Shen, Y., et al. (2019) Clinical Evaluation of Diagnosis Efficacy of Active Mycobacterium tuberculosis Complex Infection via Metagenomic Next-Generation Sequencing of Direct Clinical Samples. Frontiers in Cellular and Infection Microbiology, 9, Article 351. [Google Scholar] [CrossRef] [PubMed]
[30] 陈昕昶, 张文宏. 全基因组测序在结核病研究中的应用进展[J]. 中国防痨杂志, 2018, 40(2): 149-152.

为你推荐